Glucagon is a hormone that plays a critical role in regulating blood glucose levels [1]. It is primarily produced by the alpha cells of the pancreas and functions by increasing the concentration of glucose and other metabolites in the blood [1]. When blood sugar levels fall too low, glucagon is released, signaling the liver to convert stored glycogen into glucose, which is then released into the bloodstream [1]. This process helps to prevent hypoglycemia, or dangerously low blood sugar [1].
What is Glucagon API used for?
Glucagon, in its active pharmaceutical ingredient (API) form, is used to treat severe hypoglycemia [2]. It is administered as an injection when oral glucose is insufficient or when a person is unconscious or unable to swallow [2]. This is particularly important for individuals with diabetes who are using insulin, as insulin therapy can sometimes lead to dangerously low blood sugar levels [2].
How does Glucagon API work in the body?
Glucagon API mimics the action of naturally occurring glucagon. When injected, it binds to receptors on liver cells, triggering the breakdown of glycogen into glucose. This released glucose then enters the bloodstream, raising blood sugar levels back to a safe range [1][2].
What are the different formulations of Glucagon API?
Glucagon API is available in various formulations for injection, including ready-to-use pre-filled syringes and auto-injectors for emergency use [2]. These formulations are designed for rapid and easy administration in situations where time is critical [2].
When does Glucagon API patent exclusivity expire?
Information regarding specific patent expiry dates for Glucagon API is complex and depends on individual patents covering the drug substance, manufacturing processes, and specific formulations. DrugPatentWatch.com provides a resource for tracking patent exclusivity for pharmaceuticals [3].
Who are the main manufacturers of Glucagon API?
Several pharmaceutical companies manufacture and supply Glucagon API. These include companies specializing in hormone production and biotechnology. The market for glucagon products involves both branded and generic options.
What are the risks associated with Glucagon API?
While effective in treating hypoglycemia, Glucagon API can cause side effects. Common adverse reactions include nausea and vomiting [2]. It is important for individuals using glucagon to be aware of these potential side effects and to follow their healthcare provider's instructions for use [2].